US 12,187,672 B2
1,2-diacylglycerol compound, preparation method therefor, and immunomodulator containing same as active ingredient
Ki Young Sohn, Seoul (KR); Jae Wha Kim, Daejeon (KR); Sun Young Yoon, Daejeon (KR); Chang Hyun Yoo, Daejeon (KR); and Jin Seon Jeong, Cheonan-si (KR)
Assigned to ENZYCHEM LIFESCIENCES CORPORATION, Jecheon-si (KR)
Appl. No. 16/978,873
Filed by ENZYCHEM LIFESCIENCES CORPORATION, Jecheon-si (KR)
PCT Filed Mar. 25, 2019, PCT No. PCT/KR2019/003437
§ 371(c)(1), (2) Date Sep. 8, 2020,
PCT Pub. No. WO2019/190137, PCT Pub. Date Oct. 3, 2019.
Claims priority of application No. 10-2018-0034537 (KR), filed on Mar. 26, 2018.
Prior Publication US 2021/0002197 A1, Jan. 7, 2021
Int. Cl. C07C 41/09 (2006.01); A23L 33/115 (2016.01); A61K 31/22 (2006.01); A61K 31/23 (2006.01); A61P 31/00 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); C07C 69/30 (2006.01); C07C 69/587 (2006.01)
CPC C07C 41/09 (2013.01) [A61P 37/02 (2018.01)] 10 Claims
 
1. A 1,2-diacylglycerol compound represented by following Chemical formula 2,

OG Complex Work Unit Chemistry
wherein in Chemical formula 2, R1 is octanoyl, lauroyl, decanoyl or palmitoyl, R3 is butyryl, 2-methylbutyryl, pivaloyl or linoleoyl, and R2 is methyl group, ethyl group, propyl group or isopropyl group.